DiaMedica Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.9% | -30.9% | -29.8% |
| FY2022 | -43.0% | -43.0% | -39.8% |
| FY2023 | -38.0% | -38.0% | -35.8% |
| FY2024 | -60.0% | -60.0% | -52.7% |
| FY2025 | -58.4% | -58.4% | -53.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.9% | -30.9% | -29.8% |
| FY2022 | -43.0% | -43.0% | -39.8% |
| FY2023 | -38.0% | -38.0% | -35.8% |
| FY2024 | -60.0% | -60.0% | -52.7% |
| FY2025 | -58.4% | -58.4% | -53.4% |